Skip to content
AZBio Logo
  • Members
    • Why Join AZBio
    • Join AZBio
      • AZBio Member Application
    • Support AZBio
    • Member Directory
      • My Member Profile
    • Save with AZBio Purchasing Power
    • AZBio Career Center
  • News
    • In The Loop
    • Health Innovation Spotlights
    • AZBio.TV
    • Arizona Bio News from Business Wire
    • BIO News from Business Wire
  • Events
    • AZBio Trailblazer Awards
    • Looking back on Arizona Bioscience Week 2023
    • Arizona Bioscience Week 2024
    • White Hat Life Science Investor Conference 2024
  • Resources
    • AZBioPEERS
    • AZBioPEERS Mentoring Program
    • How a Professional Employer Org (PEO) Can Support Your Business
    • AZBio Career Center
      • Career Planning Portal
    • Telling Arizona’s Biotech Story
    • Arizona BioMap
    • Resource Library
  • Advocacy
    • AZBio Legislative Watch List 2023
    • AZBio Public Policy Principles
    • Voice of the Patient
    • Find My Legislator
    • Request to Speak Instructions
    • Arizona Congressional Delegation
    • 2023 Congressional Calendar
    • BIO Advocacy Tool Kit
    • Government Affairs Committee
    • Government Affairs Blog
  • About AZBio
    • What We Do
    • Arizona Bioindustry Fact Sheet
    • AZBio History
    • AZBio Staff
    • AZBio Board of Directors
    • Privacy Policy
  • Contact
  • Member Login
  • Menu

Category Archives: Health

Crispr in diagnostics will be a revolution . . . eventually.

Posted on Fri/28/OctoberFri/28/October by AZBio

Two years ago this month, the Nobel Prize in Chemistry was awarded to two of the pioneers of the Crispr DNA-editing technique. Since then, it has displaced all other laboratory techniques for that purpose by virtue of its accuracy, simplicity, ease of use, and low cost.

How it works and why it was Nobel-worthyContinue reading→

Check out the Nanotechnology Startup Challenge in Cancer

Posted on Mon/5/OctoberMon/9/November by AZBio

The National Cancer Institute’s (NCI) Alliance for Nanotechnology in Cancer and the Center for Advancing Innovation have partnered to create a “first of a kind” Nanotechnology Startup Challenge in Cancer or NSC2.Continue reading→

Scientists determine structure of important drug target using groundbreaking approach

Posted on Fri/24/JulySun/13/September by AZBio

Tempe, Arizona (July 23, 2015) – Using the brightest X-ray laser in the world, scientists have determined the structure of a molecular complex that is responsible for our sense of sight.Continue reading→

Paradigm Initiates Genomic Profiling for Pharmatech’s AccessPPM Cancer Registry Program

Posted on Fri/8/AugustWed/17/December by AZBio

Novel clinical trial matching protocol enables greater access to genomic profiling and targeted clinical studies for cancer patients nationwide.Continue reading→

NAU Reseachers Study Link Between Uranium Exposure And Skin Cancer,

Posted on Fri/8/AugustWed/17/December by AZBio

After years of delving deep into DNA and researching ways in which metal damage may lead to cancer, a team of researchers is taking a step back to look at the surface where one answer may have been all along.Continue reading→

Biodesign’s Arntzen using tobacco as a way to make and deliver a promising vaccine for the Ebola virus

Posted on Wed/6/AugustWed/17/December by AZBio

Charlie Arntzen has worked tirelessly on new platforms to deliver vaccines. He has focused on plant-based vaccine delivery systems, testing a wide range of plants as possible “manufacturing platforms” for vaccines for the developing world.Continue reading→

UA Researchers Exploring If Diet Can Make You Live Longer

Posted on Tue/5/AugustWed/17/December by AZBio

UA Researchers Study Increasing Lifespan and Immune FunctionContinue reading→

FDA Approves the SynCardia Total Artificial Heart With SynHall Valves

Posted on Tue/5/AugustWed/17/December by AZBio

SynCardia Systems, Inc., now controls last key component in heart manufacturing.Continue reading→

NuvOx announces Phase Ib trial for Glioblastoma and additional NIH funding

Posted on Thu/31/JulyWed/17/December by AZBio

NuvOx Pharma, a privately held biotechnology company based in Tucson, Arizona, announced that on July 14th, it began a Phase Ib clinical trial of its new drug NVX-108 in patients with glioblastoma, a deadly form of brain cancer.Continue reading→

The Freedom® portable driver from SynCardia Receives FDA Approval for Bridge to Transplant

Posted on Wed/16/JulyWed/17/December by AZBio

TUCSON, Ariz. – July 16, 2014 –  The Freedom® portable driver received FDA approval on June 26, 2014 for use with the SynCardia temporary Total Artificial Heart as a bridge to transplantation in cardiac transplant candidates who are clinically stable.Continue reading→

Post navigation

1 2 3 4 5 6 … 23 Next »

Blog Categories

Upcoming Events

  • BioFuture 2023
            Oct 4, 2023 - New York
  • The Medtech Conference
            Oct 9, 2023 - Anaheim
  • Bisnow International Life Sciences and Biotech Conference
            Oct 11, 2023 - Philadelphia
  • ASU Annual Diagnostics Summit
            Oct 19, 2023 -
  • The brain hates losing (and other news from neuroeconomics)
            Nov 2, 2023 - Tempe
  • Western Regional Valley Fever Workshop: Emerging public health problem and mitigation strategies
            Nov 3, 2023 - Phoenix
  • Comparative Medicine Symposium
            Nov 30, 2023 - Scottsdale
  • Comparative Medicine Symposium 2023 : Leveraging Naturally Occurring Diseases in Dogs to Advance Biomedical Innovations
            Nov 30, 2023 - Scottsdale
  • AZBio Trailblazer Awards
            Dec 14, 2023 - Phoenix
  • all events

Blog Archive

  • Click the image for the latest news about AZBio Members
  • Click the image to learn more
  • Click the image to learn more
  • Click the image to learn more
  • Click the image to learn more about AZBio Membership
  • Click the image to learn more
  • Click the image to enter the AZBio Career Center
  • Click the image to learn more about the AZBio/AZAdvances Public Information Campaign
  • Patients are why we do what we do. Click the image to listen to their stories.

Disclaimer
Privacy Statement (US) Privacy Statement (EU)
Cookie Policy (EU)
Privacy Statement (UK)
Cookie Policy (UK)
Do Not Sell My Personal Information

Copyright 2023 | Arizona Bioindustry Association, Inc.
A SiteOrigin Theme
Manage Cookie Consent
We use cookies to optimize our website and our service.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}